Searched for
ASTRAZENECA SHARE PRICE
Global Markets | European markets dip as investors eye earnings, Iran conflict continues to weighEuropean shares dipped on Wednesday, as investors turned their focus to a packed day of corporate earnings, while a continuing U.S.-Iran im...
AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
Chart Check: AstraZeneca Pharma gives breakout from 7-month consolidation phase; where is the stock headed?Experts predict that AstraZeneca Pharma's stock price may hit 4000 levels in the next month after breaking out from a 7-month-long consolid...
AstraZeneca Pharma gains despite fall in Q2 profit; here's whyIn the July-September quarter, AstraZeneca Pharma India reported a decline of 54.65 per cent in net profit to Rs 11.94 crore. In the same p...
AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 crRevenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago...
AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
Stock market news: AstraZeneca Pharma shares tank nearly 6%A total of 21,919 shares changed hands on the counter till 11:12AM (IST).
Trending stocks: AstraZeneca Pharma shares gain over 1%A total of 1,321 shares changed hands on the counter till 11:40AM (IST).
AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
Under Sebi lens, Elliott offloads 6% in AstraZenecaSebi’s deadline to investigate dealings of the Elliott Group with regard to the de-listing of Astra-Zeneca ended on March 11.
AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
AstraZeneca rallies 15%, hits 52-week high ahead of board meet; up 50% in a monthAfter rallying 20 per cent in trade yesterday, AstraZeneca Pharma put up a strong show today ahead of the company's board meet on Wednesday.
AstraZeneca jumps 20 per cent on delisting planAstraZeneca’s India unit has revived its plan of delisting the co from the stock markets, an announcement that sent company’s shares soarin...
AstraZeneca Pharma OFS begins at Rs 490/share; stock tanks 17%The OFS is being launched to meet SEBI's norm on minimum 25 pc public shareholding for private sector listed companies.
- AstraZeneca Pharma promoter to sell stake in Indian arm
AstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delisting
AstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- AstraZeneca Pharma to delist from India; shares jump 20 pc
AstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...